Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 16/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 13/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 13/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 12/20 | 0.58 |
| ▸ | HDAC3 | O15379 | 11/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 11/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 9/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 9/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 9/20 | 0.58 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8230787 | 0.82 | HDAC1 (0.64) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL8227045 | 0.80 | MAPT (0.54) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL8227619 | 0.79 | HDAC1 (0.61) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL8272150 | 0.79 | HDAC1 (0.65) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL13213519 | 0.77 | HDAC1 (0.69) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL8229145 | 0.76 | ALDH1A1 (0.60) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL10807052 | 0.75 | GSTO1 (0.73) | GSTO1LMNA | |
| SCHEMBL24359677 | 0.74 | HDAC1 (0.78) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL8271089 | 0.74 | KMT2A (0.55) | HDAC1HDAC6HDAC9HDAC2HDAC3 | |
| SCHEMBL8271103 | 0.73 | HDAC1 (0.52) | HDAC1HDAC6HDAC9HDAC2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8653278-B2 | Isoform selective HDAC inhibitors | GEORGETOWN UNIVERSITY (US) | 2014-02-18 | — | — | US | disclosed |
| US-8653278-B2 | Isoform selective HDAC inhibitors | GEORGETOWN UNIVERSITY (US) | 2014-02-18 | — | — | US | disclosed |
| US-20100196502-A1 | Isoform Selective HDAC Inhibitors | GEORGETOWN UNIVERSITY (US) | 2010-08-05 | — | — | US | disclosed |
| US-20100196502-A1 | Isoform Selective HDAC Inhibitors | GEORGETOWN UNIVERSITY (US) | 2010-08-05 | — | — | US | disclosed |
| WO-2008019025-A2 | ISOFORM-SELECTIVE HDAC INHIBITORS | GEORGETOWN UNIVERSITY (US) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100196502-A1 | Isoform Selective HDAC Inhibitors | HDAC5, HDAC6, HDAC3 | HDAC1 4/4885HDAC6 2/4885HDAC9 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.